San Diego, CA – DexCom, Inc. presented at the Wells Fargo 2024 Healthcare Conference on September 4, 2024. The CEO, Kevin Sayer, and CFO, Jereme Sylvain, engaged in a fireside chat format with analysts. The discussion revolved around the company’s performance, market growth, competition, and the launch of their new product, Stelo, aimed at type 2 diabetes management.

When asked about the growth potential of the continuous glucose monitoring (CGM) market, Sayer expressed confidence in its continued growth, citing opportunities in different segments, including type 1 and type 2 diabetes. He highlighted plans for expansion into new geographies and the significance of CGM in diabetes management.

Regarding competition and market share, Sayer acknowledged challenges faced, particularly in the Durable Medical Equipment (DME) channel. He outlined strategies to address issues, including intensifying communication with sales teams and DME distributors. Sylvain added insights into the impact of sales force expansion and efforts to stabilize the DME market.

The discussion also delved into DexCom’s upcoming product, the G7, with an anticipated 15-day wear time. Sayer expressed confidence in obtaining FDA approval and emphasized the company’s commitment to delivering innovative and reliable products to consumers.

Transitioning to Stelo, DexCom’s new product designed for type 2 diabetes management, Sayer highlighted the strong demand and positive feedback from users. He discussed the pricing strategy and subscription model, emphasizing the importance of accessibility and user experience.

In addressing concerns about meeting revenue targets for Stelo, Sylvain mentioned a strong start in terms of customer interest and engagement. He highlighted the company’s plans to leverage existing customer bases and market research to drive adoption and revenue growth.

Sayer concluded the session with a positive outlook for DexCom, emphasizing the company’s strong product pipeline and growth potential in the medical device market. He acknowledged current challenges but expressed confidence in overcoming them and achieving long-term success.